Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
Ananworanich
Jintanat
J
Siangphoe
Umaporn
U
Mahanontharit
Apicha
A
Hill
Andrew
A
Hirschel
Bernard
B
Ruxrungtham
Kiat
K
D000225:Adenine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D002214:Capsules; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005782:Gels; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage* / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage* / Q000627:therapeutic use; D019258:Saquinavir / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000068698:Tenofovir
D002214:Capsules; D005782:Gels; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; D019258:Saquinavir; D019438:Ritonavir